Oncology Institute Correlations

TOI Stock  USD 1.00  0.01  0.99%   
The current 90-days correlation between Oncology Institute and Medical Facilities is -0.02 (i.e., Good diversification). The correlation of Oncology Institute is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Oncology Institute Correlation With Market

Significant diversification

The correlation between Oncology Institute and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oncology Institute and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Oncology Institute. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

Moving together with Oncology Stock

  0.61LNSR LENSAR IncPairCorr

Moving against Oncology Stock

  0.69NHC National HealthCarePairCorr
  0.45ESPR Esperion TherapeuticsPairCorr
  0.39INNV InnovAge Holding Corp Earnings Call This WeekPairCorr
  0.38PNTG Pennant GroupPairCorr
  0.31EHC Encompass Health Corp Earnings Call This WeekPairCorr
  0.74002382 Blue Sail MedicalPairCorr
  0.68600587 Shinva Medical InstrumentPairCorr
  0.67300981 Zhonghong Pulin MedicalPairCorr
  0.65300869 Contec Medical SystemsPairCorr
  0.64301370 GKHT Medical TechnologyPairCorr
  0.6DERM Journey Medical Corp Upward RallyPairCorr
  0.6688198 Beijing Balance MedicalPairCorr
  0.5LFCR Lifecore BiomedicalPairCorr
  0.48AQST Aquestive TherapeuticsPairCorr
  0.46688139 Qingdao Haier BiomedicalPairCorr
  0.43688626 Xiangyu MedicalPairCorr
  0.35301367 BMC MedicalPairCorr
  0.35VTI Visioneering TechnologiesPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AGLFSNUY
PNTGRMYHY
BKDRMYHY
BKDPNTG
CANOMFCSF
LFSTCANO
  
High negative correlations   
LFSTRMYHY
BKDLFST
PNTGLFST
BKDCANO
PNTGCANO
BKDMFCSF

Risk-Adjusted Indicators

There is a big difference between Oncology Stock performing well and Oncology Institute Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oncology Institute's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
RMYHY  1.30 (0.52) 0.00  2.09  0.00 
 0.00 
 26.48 
MFCSF  1.20  0.08  0.00  1.30  1.11 
 3.58 
 7.68 
JNHMF  12.05  3.88  0.00  7.03  0.00 
 20.83 
 250.46 
MCIOF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
FSNUY  1.06  0.05  0.00  0.20  1.14 
 2.20 
 5.16 
CANO  4.54  0.40  0.04 (0.31) 4.70 
 11.11 
 36.13 
LFST  1.57  0.19  0.07  0.47  1.69 
 3.84 
 13.30 
AGL  5.41  0.70  0.08  1.33  7.81 
 11.56 
 39.93 
PNTG  1.66 (0.29) 0.00 (1.93) 0.00 
 3.76 
 8.51 
BKD  1.78 (0.40) 0.00 (1.99) 0.00 
 3.10 
 14.96 

Oncology Institute Corporate Management

FACHE MDChief OfficerProfile
Mark EsqGeneral CounselProfile
Rob CarterSenior FinanceProfile
Bradford HivelyCEO DirectorProfile
Rakesh MBADirector TechnologyProfile
Laura SzitarChief OfficerProfile
Richard BaraschExecutive BoardProfile